Odyssey Health (ODYY) Cash & Equivalents (2014 - 2026)
Odyssey Health (ODYY) reported Cash & Equivalents of $297806.0 for Q2 2026, up 9247.33% year-over-year from $3186.0 in Q2 2025, and down 51.68% sequentially from $616327.0 in Q1 2026.
Odyssey Health (ODYY) Cash & Equivalents (2014 - 2026) Analysis & Trends
Odyssey Health has disclosed Cash & Equivalents across 13 years of filings, most recently posting $297806.0 for Q2 2026.
- Quarterly Cash & Equivalents rose 9247.33% year-over-year to $297806.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $297806.0 (up 9247.33% YoY) and the FY2025 annual result came in at $19084.0, up 702.19% from the prior year.
- Cash & Equivalents declined to $297806.0 in Q2 2026, from $616327.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $616327.0 in Q1 2026 and bottomed at $1234.0 in Q2 2023.
- The 5-year median for Cash & Equivalents is $52182.0 (2022), against an average of $113889.8.
- Year-over-year, Cash & Equivalents tumbled 99.54% in 2023 and surged 9247.33% in 2026.
- Odyssey Health's Cash & Equivalents stood at $50499.0 in 2022, then soared by 291.85% to $197882.0 in 2023, then tumbled by 72.78% to $53865.0 in 2024, then tumbled by 52.5% to $25586.0 in 2025, then surged by 1063.94% to $297806.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $297806.0, $616327.0, and $25586.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Odyssey Health | - | - | - | 297,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 297,806.00 |
| Jan 31, 2026 | 616,327.00 |
| Oct 31, 2025 | 25,586.00 |
| Jul 31, 2025 | 19,084.00 |
| Apr 30, 2025 | 3,186.00 |
| Jan 31, 2025 | 7,187.00 |
| Oct 31, 2024 | 53,865.00 |
| Jul 31, 2024 | 2,379.00 |
| Apr 30, 2024 | 66,014.00 |
| Jan 31, 2024 | 166,140.00 |
| Oct 31, 2023 | 197,882.00 |
| Jul 31, 2023 | 36,865.00 |
| Apr 30, 2023 | 1,234.00 |
| Jan 31, 2023 | 35,792.00 |
| Oct 31, 2022 | 50,499.00 |
| Jul 31, 2022 | 72,534.00 |
| Apr 30, 2022 | 266,300.00 |
| Jan 31, 2022 | 131,337.00 |
| Oct 31, 2021 | 471,140.00 |
| Jul 31, 2021 | 72,534.00 |